Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-17

FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)